Literature DB >> 16082515

Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice.

A Fredriksson1, P Eriksson, T Archer.   

Abstract

C57/BL6 mice were administered either 7.5 mg Fe(2+)/kg or vehicle (saline) postnatally on days 10-12 after birth. From 61 days of age onwards for 21 days, groups of mice were administered either clozapine (1 or 5 mg/kg, s.c.) or haloperidol (1 mg/kg, s.c.) or vehicle (Tween-80). Twenty-four hours after the final injection of either neuroleptic compound or vehicle, spontaneous motor activity was measured over a 60-min interval. Following this, each animal was removed, injected apomorphine (1 mg/kg, s.c.) and replaced in the same test chamber. It was found that postnatal administration of Fe(2+) at the 7.5 mg/kg dose level reduced activity during the initial 20-min periods (0-20 and 20-40 min) and then induced hyperactivity during the final 20-min period over all three parameters of activity. Subchronic treatment with the higher, 5 mg/kg, dose of clozapine abolished or attenuated the hypoactivity in by postnatal Fe(2+) during the 1(st) two 20-min periods over all three parameters of activity. Subchronic treatment with the higher, 5 mg/kg, dose of clozapine abolished or attenuated the hyperactivity in by postnatal Fe(2+) during the 3(rd) and final 20-min period. Subchronic administration of haloperidol, without postnatal iron, increased the level of both locomotion (1(st) 20 min) and rearing (2(nd) 20 min) activity. Postnatal administration of Fe(2+) at the 7.5 mg/kg dose increased the levels of both locomotion and rearing, but not total activity, following administration of apomorphine (1 mg/kg). Subchronic administration of clozapine, at both the 1 and 5 mg/kg doses, reduced the increased locomotor activity caused by postnatal Fe(2+), whereas clozapine, 5 mg/kg, elevated further the postnatal Fe(2+)-induced increased in rearing. Subchronic administration of clozapine, at both the 1 and 5 mg/kg doses, and haloperidol, 1 mg/kg, increased the level of locomotor following administration of apomorphine (1 mg/kg) in mice treated postnatally with vehicle, whereas only clozapine increased the level of rearing. Correlational analyses indicated that both apomorphine-induced locomotion and rearing were highly correlated with the total iron content in the basal ganglia, thereby offering direct evidence of the linear relationship between iron content in the basal ganglia and the behavioural expression of DA D(2)-receptor supersensitivity in mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16082515     DOI: 10.1007/s00702-005-0307-3

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  43 in total

1.  Increased nigral iron content in postmortem parkinsonian brain.

Authors:  D T Dexter; F R Wells; F Agid; Y Agid; A J Lees; P Jenner; C D Marsden
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321

2.  Prevention of neuroleptic-induced dopamine D2 receptor supersensitivity by chronic iron salt treatment.

Authors:  D Ben-Shachar; B Pinhassi; M B Youdim
Journal:  Eur J Pharmacol       Date:  1991-09-17       Impact factor: 4.432

3.  Tolerance to behavioral effects of haloperidol.

Authors:  A Campbell; R J Baldessarini
Journal:  Life Sci       Date:  1981-09-28       Impact factor: 5.037

4.  Aging and the regulation of striatal dopaminergic mechanisms in mice.

Authors:  P K Randall; J A Severson; C E Finch
Journal:  J Pharmacol Exp Ther       Date:  1981-12       Impact factor: 4.030

5.  Memory deficits in adult rats following postnatal iron administration.

Authors:  N Schröder; A Fredriksson; M R Vianna; R Roesler; I Izquierdo; T Archer
Journal:  Behav Brain Res       Date:  2001-09-28       Impact factor: 3.332

Review 6.  Clozapine: a clinical review of adverse effects and management.

Authors:  Mohammad Masud Iqbal; Atiq Rahman; Zahid Husain; Syed Zaber Mahmud; Wlliam G Ryan; Jacqueline M Feldman
Journal:  Ann Clin Psychiatry       Date:  2003-03       Impact factor: 1.567

7.  Iron-dependent enzymes in Parkinson's disease.

Authors:  H Reichmann; B Janetzky; P Riederer
Journal:  J Neural Transm Suppl       Date:  1995

8.  Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron.

Authors:  B P Drayer; W Olanow; P Burger; G A Johnson; R Herfkens; S Riederer
Journal:  Radiology       Date:  1986-05       Impact factor: 11.105

Review 9.  Iron modulates neuroleptic-induced effects related to the dopaminergic system.

Authors:  D Ben-Shachar; E Livne; I Spanier; R Zuk; M B Youdim
Journal:  Isr J Med Sci       Date:  1993-09

10.  Neurobehavioural deficits following postnatal iron overload: II Instrumental learning performance.

Authors:  T Archer; N Schröder; A Fredriksson
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

View more
  3 in total

1.  Functional consequences of iron overload in catecholaminergic interactions: the Youdim factor.

Authors:  Trevor Archer; Anders Fredriksson
Journal:  Neurochem Res       Date:  2007-08-12       Impact factor: 3.996

2.  Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice.

Authors:  A Fredriksson; T Archer
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

3.  Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice.

Authors:  Anders Fredriksson; Trevor Archer
Journal:  Neurotox Res       Date:  2006-06       Impact factor: 3.911

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.